DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q1 2015 holdings

$3.09 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 124 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 71.2% .

 Value Shares↓ Weighting
ASPX BuyAUSPEX PHARMACEUTICALS INC$446,112,000
+188.2%
4,449,103
+50.9%
14.45%
+159.9%
HZNP BuyHORIZON PHARMA PLC$332,226,000
+120.3%
12,792,689
+9.3%
10.76%
+98.6%
BuyALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0$98,882,000
+672.8%
100,750,000
+675.0%
3.20%
+596.3%
ABBV NewABBVIE INC$89,800,0001,534,000
+100.0%
2.91%
NXTM BuyNXSTAGE MEDICAL INC$87,764,000
+1.7%
5,073,050
+5.4%
2.84%
-8.3%
ARRY  ARRAY BIOPHARMA INC$87,221,000
+55.8%
11,834,5950.0%2.82%
+40.5%
AAVL BuyAVALANCHE BIOTECHNOLOGIES IN$85,800,000
-1.6%
2,117,473
+31.1%
2.78%
-11.3%
SellHORIZON PHARMA INCnote 5.000%11/1$78,189,000
-5.2%
16,014,461
-49.6%
2.53%
-14.5%
BLUE SellBLUEBIRD BIO INC$76,243,000
-2.3%
631,309
-25.8%
2.47%
-11.9%
FLML SellFLAMEL TECHNOLOGIES SAsponsored adr$73,229,000
-18.7%
4,072,809
-22.5%
2.37%
-26.7%
DVA BuyDAVITA HEALTHCARE PARTNERS I$59,334,000
+80.1%
730,000
+67.8%
1.92%
+62.3%
 ARRAY BIOPHARMA INCnote 3.000% 6/0$56,037,000
+34.7%
45,000,0000.0%1.82%
+21.4%
INFI BuyINFINITY PHARMACEUTICALS INC$55,475,000
-14.9%
3,968,155
+2.9%
1.80%
-23.2%
UAM SellUNIVERSAL AMERN CORP NEW$55,388,000
+6.3%
5,186,148
-7.6%
1.79%
-4.2%
 INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1$54,556,000
+8.2%
47,428,0000.0%1.77%
-2.5%
ONCE NewSPARK THERAPEUTICS INC$48,917,000631,192
+100.0%
1.58%
WBA NewWALGREENS BOOTS ALLIANCE INC$43,424,000512,800
+100.0%
1.41%
ZFGN NewZAFGEN INC$41,598,0001,050,178
+100.0%
1.35%
ARNA BuyARENA PHARMACEUTICALS INC$40,332,000
+67.2%
9,229,379
+32.7%
1.31%
+50.6%
GSK BuyGLAXOSMITHKLINE PLCsponsored adr$40,297,000
+67.4%
873,185
+55.0%
1.30%
+50.9%
ELGX SellENDOLOGIX INC$40,103,000
-22.4%
2,349,351
-30.5%
1.30%
-30.0%
VNDA SellVANDA PHARMACEUTICALS INC$38,448,000
-35.1%
4,134,157
-0.1%
1.24%
-41.5%
 ENDOLOGIX INCnote 2.250%12/1$35,203,000
+1.9%
34,925,0000.0%1.14%
-8.2%
INSM SellINSMED INC$33,873,000
-2.3%
1,628,531
-27.4%
1.10%
-12.0%
GWPH NewGW PHARMACEUTICALS PLCads$33,144,000363,700
+100.0%
1.07%
ATRS BuyANTARES PHARMA INC$32,732,000
+57.2%
12,078,318
+49.0%
1.06%
+41.7%
EHTH BuyEHEALTH INC$30,622,000
-45.7%
3,264,588
+44.2%
0.99%
-51.1%
AET NewAETNA INC NEW$30,286,000284,300
+100.0%
0.98%
SAGE BuySAGE THERAPEUTICS INC$29,909,000
+211.2%
595,443
+126.7%
0.97%
+180.9%
XNCR NewXENCOR INC$29,040,0001,895,535
+100.0%
0.94%
ACHN SellACHILLION PHARMACEUTICALS IN$27,708,000
-22.5%
2,810,164
-3.8%
0.90%
-30.2%
 ACCURAY INCnote 3.750% 8/0$26,694,000
+6.8%
24,100,0000.0%0.86%
-3.7%
BuyWEBMD HEALTH CORPnote 1.500%12/0$24,433,000
+44.4%
23,000,000
+35.3%
0.79%
+30.1%
 HEARTWARE INTL INCnote 3.500%12/1$23,227,000
+6.7%
20,464,0000.0%0.75%
-3.8%
CRL NewCHARLES RIV LABS INTL INC$22,950,000289,450
+100.0%
0.74%
OFIX BuyORTHOFIX INTL N V$22,619,000
+41.0%
630,222
+18.1%
0.73%
+27.3%
ALIM BuyALIMERA SCIENCES INC$22,147,000
-1.2%
4,420,580
+9.3%
0.72%
-10.9%
PTLA SellPORTOLA PHARMACEUTICALS INC$21,810,000
+17.5%
574,546
-12.4%
0.71%
+5.8%
MCK  MCKESSON CORP$20,810,000
+9.0%
92,0000.0%0.67%
-1.7%
LOXO  LOXO ONCOLOGY INC$19,815,000
+6.0%
1,591,5460.0%0.64%
-4.5%
GILD  GILEAD SCIENCES INCput$19,626,000
+4.1%
200,0000.0%0.64%
-6.1%
INGN BuyINOGEN INC$19,251,000
+73.2%
601,772
+69.8%
0.62%
+56.4%
AERI SellAERIE PHARMACEUTICALS INC$18,996,000
-65.0%
606,118
-67.4%
0.62%
-68.4%
DYAX BuyDYAX CORP$18,957,000
+37.2%
1,131,414
+15.1%
0.61%
+23.8%
HUM NewHUMANA INC$18,924,000106,300
+100.0%
0.61%
PACB SellPACIFIC BIOSCIENCES CALIF IN$17,802,000
-55.7%
3,048,310
-40.5%
0.58%
-60.0%
TRUP SellTRUPANION INC$16,815,000
-9.4%
2,101,848
-21.5%
0.54%
-18.3%
NUVA NewNUVASIVE INC$15,554,000338,194
+100.0%
0.50%
ANTM NewANTHEM INC$15,401,00099,742
+100.0%
0.50%
NSTG BuyNANOSTRING TECHNOLOGIES INC$14,884,000
+15.7%
1,460,652
+58.2%
0.48%
+4.3%
PRTO  PROTEON THERAPEUTICS INC$14,716,000
+11.8%
1,265,3430.0%0.48%
+0.8%
IMPR BuyIMPRIVATA INC$14,359,000
+10.6%
1,025,652
+2.7%
0.46%
-0.2%
OVAS SellOVASCIENCE INC$14,139,000
-49.0%
407,108
-35.1%
0.46%
-54.0%
AACH NewAAC HLDGS INC$13,649,000446,328
+100.0%
0.44%
AXGN BuyAXOGEN INC$13,548,000
+150.3%
3,870,824
+156.7%
0.44%
+126.3%
TXMD NewTHERAPEUTICSMD INC$13,451,0002,223,310
+100.0%
0.44%
JUNO SellJUNO THERAPEUTICS INC$11,110,000
-40.6%
183,149
-48.9%
0.36%
-46.4%
STDY NewSTEADYMED LTD$10,776,0001,267,733
+100.0%
0.35%
 FLUIDIGM CORP DELnote 2.750% 2/0$10,632,000
+16.3%
10,000,0000.0%0.34%
+4.6%
TRIV SellTRIVASCULAR TECHNOLOGIES INC$10,387,000
-28.1%
990,202
-13.8%
0.34%
-35.3%
EXEL NewEXELIXIS INCput$10,280,0004,000,000
+100.0%
0.33%
GENN NewGENESIS HEALTHCARE INC$10,198,0001,432,368
+100.0%
0.33%
GNCA BuyGENOCEA BIOSCIENCES INC$10,013,000
+136.7%
844,257
+39.7%
0.32%
+113.2%
ADPTQ BuyADEPTUS HEALTH INCcl a$9,974,000
+323.0%
198,600
+215.0%
0.32%
+280.0%
KERX SellKERYX BIOPHARMACEUTICALS INC$9,744,000
-41.8%
765,450
-35.3%
0.32%
-47.5%
IMMU SellIMMUNOMEDICS INC$9,598,000
-28.7%
2,505,972
-10.7%
0.31%
-35.7%
TNXP NewTONIX PHARMACEUTICALS HLDG C$8,627,0001,365,000
+100.0%
0.28%
RIGL  RIGEL PHARMACEUTICALS INC$8,560,000
+57.3%
2,397,8550.0%0.28%
+41.3%
DSCI BuyDERMA SCIENCES INC$8,394,000
+24.9%
991,040
+37.3%
0.27%
+12.9%
ADHD NewALCOBRA LTD$7,956,0001,413,208
+100.0%
0.26%
 HEALTHWAYS INCnote 1.500% 7/0$7,816,000
-0.2%
6,700,0000.0%0.25%
-10.0%
ELOS NewSYNERON MEDICAL LTD$7,745,000625,593
+100.0%
0.25%
OXFD NewOXFORD IMMUNOTEC GLOBAL PLC$7,353,000522,250
+100.0%
0.24%
ATEC BuyALPHATEC HOLDINGS INC$7,225,000
+28.7%
4,982,738
+25.1%
0.23%
+15.8%
DBVT SellDBV TECHNOLOGIES S Asponsored adr$6,964,000
-46.8%
298,121
-38.2%
0.23%
-51.9%
TCON NewTRACON PHARMACEUTICALS INC$6,809,000485,000
+100.0%
0.22%
AMPH SellAMPHASTAR PHARMACEUTICALS IN$6,710,000
-54.7%
448,532
-64.9%
0.22%
-59.2%
STRM  STREAMLINE HEALTH SOLUTIONS$6,471,000
-18.0%
1,822,7590.0%0.21%
-26.1%
FOMX SellFOAMIX PHARMACEUTICALS LTD$6,287,000
+20.4%
679,627
-8.8%
0.20%
+8.5%
VSAR NewVERSARTIS INC$6,240,000339,703
+100.0%
0.20%
ZSPH NewZS PHARMA INC$6,202,000147,385
+100.0%
0.20%
BEAT BuyBIOTELEMETRY INC$5,702,000
+32.5%
644,300
+50.2%
0.18%
+19.4%
CLLS NewCELLECTIS S Asponsored ads$5,204,000150,506
+100.0%
0.17%
LMNS SellLUMENIS LTD$5,202,000
-6.8%
434,566
-27.3%
0.17%
-16.4%
CARA  CARA THERAPEUTICS INC$4,760,000
+0.8%
473,5880.0%0.15%
-9.4%
PRQR SellPROQR THRAPEUTICS N V$4,582,000
-44.4%
209,398
-44.9%
0.15%
-50.0%
NewTRILLIUM THERAPEUTICS INC$4,573,000226,064
+100.0%
0.15%
CDNA  CAREDX INC$4,458,000
-23.5%
804,0000.0%0.14%
-31.1%
DSCO  DISCOVERY LABORATORIES INC N$4,355,000
+2.6%
3,659,7000.0%0.14%
-7.8%
CCRN NewCROSS CTRY HEALTHCARE INC$4,349,000366,724
+100.0%
0.14%
CASM  CAS MED SYS INC$4,272,000
-19.1%
3,200,0000.0%0.14%
-27.4%
SCYX SellSCYNEXIS INC$4,090,000
-18.0%
492,781
-1.4%
0.13%
-26.3%
RTRX NewRETROPHIN INC$3,791,000158,223
+100.0%
0.12%
NewEXELIXIS INCnote 4.250% 8/1$3,762,0004,985,000
+100.0%
0.12%
DERM BuyDERMIRA INC$3,553,000
+68.7%
231,467
+99.1%
0.12%
+51.3%
SCMP NewSUCAMPO PHARMACEUTICALS INCcl a$3,501,000225,000
+100.0%
0.11%
ASND NewASCENDIS PHARMA A Ssponsored adr$3,470,000200,000
+100.0%
0.11%
STJ NewST JUDE MED INC$3,294,00050,370
+100.0%
0.11%
NVTA NewINVITAE CORP$2,793,000166,666
+100.0%
0.09%
PTN  PALATIN TECHNOLOGIES INC$2,040,000
+39.7%
2,000,0000.0%0.07%
+26.9%
KIN SellKINDRED BIOSCIENCES INC$1,994,000
-24.0%
279,204
-20.8%
0.06%
-30.9%
IMMU  IMMUNOMEDICS INCcall$1,915,000
-20.2%
500,0000.0%0.06%
-27.9%
BVX NewBOVIE MEDICAL CORP$1,673,000700,000
+100.0%
0.05%
ACAD NewACADIA PHARMACEUTICALS INC$1,610,00049,400
+100.0%
0.05%
MEIP SellMEI PHARMA INC$1,437,000
-88.6%
802,568
-72.7%
0.05%
-89.6%
PARNF SellPARNELL PHARMACEUT HLDGS LTD$1,245,000
-20.1%
253,592
-32.5%
0.04%
-28.6%
ILMN BuyILLUMINA INC$1,188,000
+61.0%
6,400
+60.0%
0.04%
+40.7%
PTBI SellPLASMATECH BIOPHARMACEUTICAL$1,099,000
-14.5%
349,908
-6.0%
0.04%
-21.7%
ALKS NewALKERMES PLC$1,067,00017,500
+100.0%
0.04%
NewCORSICANTO LTDnote 3.500% 1/1$1,044,0001,000,000
+100.0%
0.03%
AGRX  AGILE THERAPEUTICS INC$973,000
+50.9%
105,0000.0%0.03%
+39.1%
MRTX NewMIRATI THERAPEUTICS INC$965,00032,912
+100.0%
0.03%
ABT NewABBOTT LABS$602,00013,000
+100.0%
0.02%
MYL NewMYLAN N V$594,00010,000
+100.0%
0.02%
NKTR NewNEKTAR THERAPEUTICS$502,00045,600
+100.0%
0.02%
AEZS NewAETERNA ZENTARIS INC$482,000898,574
+100.0%
0.02%
RAD NewRITE AID CORP$459,00052,764
+100.0%
0.02%
MZOR NewMAZOR ROBOTICS LTDsponsored ads$470,00041,861
+100.0%
0.02%
HMSY NewHMS HLDGS CORP$462,00029,900
+100.0%
0.02%
CELG NewCELGENE CORP$403,0003,500
+100.0%
0.01%
PTBIW  PLASMATECH BIOPHARMACEUTICAL*w exp 10/24/201$319,000
+6.3%
375,0000.0%0.01%
-9.1%
ESPR NewESPERION THERAPEUTICS INC NE$232,0002,500
+100.0%
0.01%
ONTY SellONCOTHYREON INC$233,000
-69.2%
143,200
-64.1%
0.01%
-70.4%
IMRSQ  IMRIS INC$141,000
+13.7%
147,0760.0%0.01%
+25.0%
MSTX ExitMAST THERAPEUTICS INC$0-700,000
-100.0%
-0.01%
KND ExitKINDRED HEALTHCARE INC$0-37,611
-100.0%
-0.02%
ZTS ExitZOETIS INCcl a$0-25,097
-100.0%
-0.04%
EW ExitEDWARDS LIFESCIENCES CORP$0-10,000
-100.0%
-0.05%
SLXP ExitSALIX PHARMACEUTICALS INC$0-11,500
-100.0%
-0.05%
EXEL ExitEXELIXIS INCcall$0-1,000,000
-100.0%
-0.05%
FLXN ExitFLEXION THERAPEUTICS INC$0-99,847
-100.0%
-0.07%
ANTH ExitANTHERA PHARMACEUTICALS INC$0-1,691,857
-100.0%
-0.10%
OCRX ExitOCERA THERAPEUTICS INC$0-461,119
-100.0%
-0.11%
MRGE ExitMERGE HEALTHCARE INC$0-892,897
-100.0%
-0.11%
THOR ExitTHORATEC CORP$0-102,919
-100.0%
-0.12%
KBIO ExitKALOBIOS PHARMACEUTICALS INC$0-2,286,783
-100.0%
-0.14%
EGRX ExitEAGLE PHARMACEUTICALS INC$0-284,653
-100.0%
-0.16%
PFNX ExitPFENEX INC$0-625,640
-100.0%
-0.16%
BDSI ExitBIODELIVERY SCIENCES INTL IN$0-464,083
-100.0%
-0.20%
ExitSPECTRANETICS CORPmtnf 2.625% 6/0$0-5,439,000
-100.0%
-0.25%
CNXR ExitCONNECTURE INC$0-799,750
-100.0%
-0.26%
TRNX ExitTORNIER N V$0-288,971
-100.0%
-0.26%
ExitACCURAY INCnote 3.500% 2/0$0-5,000,000
-100.0%
-0.27%
KITE ExitKITE PHARMA INC$0-155,799
-100.0%
-0.32%
ICPT ExitINTERCEPT PHARMACEUTICALS IN$0-60,393
-100.0%
-0.34%
HTWR ExitHEARTWARE INTL INC$0-164,800
-100.0%
-0.44%
ARAY ExitACCURAY INC$0-1,870,943
-100.0%
-0.51%
RMD ExitRESMED INC$0-296,300
-100.0%
-0.60%
CBST ExitCUBIST PHARMACEUTICALS INC$0-210,200
-100.0%
-0.76%
ExitTESARO INCnote 3.000%10/0$0-27,123,000
-100.0%
-1.22%
HUM ExitHUMANA INCcall$0-280,000
-100.0%
-1.44%
NVRO ExitNEVRO CORP$0-1,047,093
-100.0%
-1.46%
AGN ExitALLERGAN INCcall$0-200,000
-100.0%
-1.53%
RNA ExitPROSENSA HLDG N V$0-3,316,434
-100.0%
-2.23%
ExitAMAG PHARMACEUTICALS INCnote 2.500% 2/1$0-45,020,000
-100.0%
-2.69%
AGN ExitALLERGAN INC$0-606,601
-100.0%
-4.63%
AUXL ExitAUXILIUM PHARMACEUTICALS INC$0-6,267,382
-100.0%
-7.74%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
  • View 13F-HR/A filed 2015-08-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERIE PHARMACEUTICALS INC36Q3 20223.6%
CENTENE CORP DEL30Q3 20233.0%
BIOCRYST PHARMACEUTICALS INC29Q3 20232.2%
MOLINA HEALTHCARE INC26Q3 20221.7%
EHEALTH INC25Q3 20202.0%
INTERCEPT PHARMACEUTICALS IN24Q1 20232.2%
MYLAN NV23Q3 20206.2%
PORTOLA PHARMACEUTICALS INC23Q1 20196.0%
BROOKDALE SR LIVING INC23Q3 20232.2%
ALIMERA SCIENCES INC23Q3 20190.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
DA32 Life Science Tech Acquisition Corp.August 01, 20235,145,00091.1%
CareMax, Inc.March 13, 202318,691,42316.4%
CareMax, Inc.June 02, 202218,691,42320.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings
TypeFiled
32024-03-19
42024-03-19
42024-03-12
32024-03-08
42024-02-16
13F-HR2024-02-14
42024-02-08
32024-02-01
42023-11-21
13F-HR2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (3087399000.0 != 3087400000.0)
  • The reported has been amended

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings